Table 1.
Characteristics | Expression of HAVCR1 | p value | |
---|---|---|---|
Low | High | ||
Age | 0.067 | ||
<60 | 42 | 57 | |
≥60 | 111 | 96 | |
Gender | 0.813 | ||
Female | 56 | 56 | |
Male | 95 | 97 | |
Grade | 0.478 | ||
G1+G2 | 60 | 54 | |
G3 | 93 | 99 | |
Clinical stage | 0.359 | ||
I+II | 74 | 66 | |
III+IV | 79 | 87 | |
Pathologic-T | 0.290 | ||
T1+T2 | 34 | 42 | |
T3+T4 | 119 | 111 | |
Pathologic-N | 0.711 | ||
N0 | 49 | 46 | |
N1 | 104 | 107 | |
Pathologic-M | 0.644 | ||
M0 | 144 | 142 | |
M1 | 9 | 11 | |
Death | 0.002∗ | ||
Yes | 49 | 75 | |
No | 104 | 78 |
T: tumor status; N: regional lymph node status; M: metastasis status. ∗Significant correlation.